Articles with "use biologics" as a keyword



Photo by videoqueenstl from unsplash

American Academy of Periodontology best evidence consensus statement on the use of biologics in clinical practice

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Periodontology"

DOI: 10.1002/jper.22-0361

Abstract: Abstract A biologic is a therapeutic agent with biological activity that is administered to achieve an enhanced regenerative or reparative effect. The use of biologics has progressively become a core component of contemporary periodontal practice.… read more here.

Keywords: practice; consensus; use biologics; periodontology ... See more keywords
Photo from wikipedia

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Sign Up to like & get
recommendations!
Published in 2017 at "Autoimmunity reviews"

DOI: 10.1016/j.autrev.2017.04.011

Abstract: BACKGROUND/PURPOSE Despite conventional immunosuppressants, active and steroid-dependent systemic lupus erythematosus (SLE) represents a therapeutic challenge. Only one biologic, belimumab, has been approved, but other biologics are sometimes used off-label. Given the lack of evidence-based data… read more here.

Keywords: systemic lupus; lupus erythematosus; recommendations use; expert recommendations ... See more keywords
Photo by mnzoutfits from unsplash

Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitis.

Sign Up to like & get
recommendations!
Published in 2021 at "European journal of internal medicine"

DOI: 10.1016/j.ejim.2021.10.028

Abstract: OBJECTIVE To describe the efficacy and safety of off-label use of biologics for refractory and/or relapsing granulomatosis with polyangiitis (GPA). METHODS We conducted a French retrospective study including GPA patients who received off-label biologics for… read more here.

Keywords: treatment; refractory relapsing; label use; use biologics ... See more keywords
Photo from archive.org

Hip Preservation Techniques: The Use of Biologics to Improve Outcomes

Sign Up to like & get
recommendations!
Published in 2020 at "Operative Techniques in Sports Medicine"

DOI: 10.1016/j.otsm.2020.150761

Abstract: ABSTRACT The use of biologic adjuvants in orthopedic injuries continues to expand along with the comprehension of the healing and regeneration mechanisms of tissues. Biological treatments represent a potentially attractive option for a number of… read more here.

Keywords: outcomes hip; improve outcomes; biologics improve; hip preservation ... See more keywords
Photo by nampoh from unsplash

Biologics in pediatric psoriasis – efficacy and safety

Sign Up to like & get
recommendations!
Published in 2018 at "Expert Opinion on Drug Safety"

DOI: 10.1080/14740338.2018.1391787

Abstract: ABSTRACT Introduction: Childhood psoriasis is a special situation that is a management challenge for the treating dermatologist. As is the situation with traditional systemic agents, which are commonly used in managing severe psoriasis in children,… read more here.

Keywords: pediatric psoriasis; safety; biologics pediatric; managing severe ... See more keywords
Photo from wikipedia

Use of biologics in chronic sinusitis with nasal polyps.

Sign Up to like & get
recommendations!
Published in 2019 at "Current Opinion in Allergy and Clinical Immunology"

DOI: 10.1097/aci.0000000000000540

Abstract: PURPOSE OF REVIEW Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory condition with different endotypes between patients from eastern or western countries. Targeted biologics are currently used to treat CRSwNP, but the outcomes… read more here.

Keywords: nasal polyps; biologics chronic; use biologics; chronic sinusitis ... See more keywords
Photo from wikipedia

Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine

Sign Up to like & get
recommendations!
Published in 2022 at "Current Opinion in Pulmonary Medicine"

DOI: 10.1097/mcp.0000000000000861

Abstract: Purpose of review There are multiple FDA-approved biologics to treat poorly controlled moderate-to-severe asthma. Given the heterogeneity of asthma and the lack of head-to-head data between biologics, selecting the best biologic for a patient can… read more here.

Keywords: use biologics; head; moderate severe; medicine use ... See more keywords
Photo from wikipedia

The good, the bad and the malignant

Sign Up to like & get
recommendations!
Published in 2018 at "British Journal of Dermatology"

DOI: 10.1111/bjd.17022

Abstract: Compared with conventional systemic treatment modalities such as methotrexate, the superior efficacy and absence of cumulative toxicity have led to a widespread uptake and use of biologics for treatment of psoriasis and a number of… read more here.

Keywords: risk; patients psoriasis; treatment; cancer ... See more keywords
Photo by solenfeyissa from unsplash

Use of biologics in non‐infectious uveitis: the situation in northern England

Sign Up to like & get
recommendations!
Published in 2020 at "Internal Medicine Journal"

DOI: 10.1111/imj.14799

Abstract: 1 Zagora S, McCluskey P. Biologic therapy for uveitis: a new beginning. Intern Med J 2019; 49: 1349–51. 2 Trivedi A, Katelaris C. The use of biologic agents in the management of uveitis. Intern Med… read more here.

Keywords: biologics non; use; infectious uveitis; uveitis situation ... See more keywords
Photo by nci from unsplash

The Cretan Registry of the use of Biologics in Severe Asthma (CREBS) of the University Hospital of Heraklion,Greece

Sign Up to like & get
recommendations!
Published in 2020 at "European Respiratory Journal"

DOI: 10.1183/13993003.congress-2020.2238

Abstract: Introduction: Real-world data on the use and effectiveness of severe asthma biologics are useful as they confirm the findings of RCTs. The Cretan Registry of the use of Biologics in Severe Asthma (CREBS) is a… read more here.

Keywords: treatment; severe asthma; registry; cretan registry ... See more keywords
Photo by usgs from unsplash

Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Sign Up to like & get
recommendations!
Published in 2022 at "ERJ Open Research"

DOI: 10.1183/23120541.00273-2022

Abstract: Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown. Materials and methods The European… read more here.

Keywords: use biologics; europe; heterogeneity use; severe asthma ... See more keywords